Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia

被引：72

作者：

Ghia, Paolo ^{[1
,2
]}

Scarfo, Lydia ^{[1
,2
]}

Perez, Susan ^{[3
]}

Pathiraja, Kumudu ^{[3
]}

Derosier, Martha ^{[3
]}

Small, Karen ^{[3
]}

Sisk, Christine McCrary ^{[3
]}

Patton, Nigel ^{[4
]}

机构：

[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy

[2] IRCCS Ist Sci San Raffaele, Milan, Italy

[3] Merck & Co Inc, Kenilworth, NJ USA

[4] Auckland City Hosp, Auckland, New Zealand

来源：

BLOOD | 2017年 / 129卷 / 13期

关键词：

DEPENDENT KINASE INHIBITOR; SCH; 727965; CANCER; FLAVOPIRIDOL; FLUDARABINE; CELLS; MALIGNANCIES; APOPTOSIS; IBRUTINIB; SCHEDULE;

D O I：

10.1182/blood-2016-10-748210

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1876 / 1878

页数：3

共 50 条

[31] Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study [J].

Van Den Neste, Eric ;

Cazin, Bruno ;

Janssens, Ann ;

Gonzalez-Barca, Eva ;

Jose Terol, Maria ;

Levy, Vincent ;

Perez de Oteyza, Jaime ;

Zachee, Pierre ;

Saunders, Andrew ;

de Frias, Merce ;

Campas, Clara .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) :581-591

[32] Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia [J].

Robak, Tadeusz ;

Smolewski, Piotr ;

Cebula, Barbara ;

Grzybowska-Izydorczyk, Olga ;

Blonski, Jerzy Z. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (02) :107-113

[33] Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation [J].

Langerbeins, Petra ;

Busch, Raymonde ;

Anheier, Nadine ;

Duerig, Jan ;

Bergmann, Manuela ;

Goebeler, Maria-Elisabeth ;

Hurtz, Hans-Juergen ;

Stauch, Martina B. ;

Stilgenbauer, Stephan ;

Doehner, Hartmut ;

Fink, Anna-Maria ;

Cramer, Paula ;

Fischer, Kirsten ;

Wendtner, Clemens-Martin ;

Hallek, Michael ;

Eichhorst, Barbara .

AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) :E239-E243

[34] Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia [J].

Owen, Carolyn ;

Eisinga, Sarah ;

Banerji, Versha ;

Johnson, Nathalie ;

Gerrie, Alina S. ;

Aw, Andrew ;

Chen, Christine ;

Robinson, Sue .

LEUKEMIA RESEARCH, 2023, 133

[35] Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia [J].

Kubeczko, Marcin ;

Nowara, Elzbieta ;

Spychalowicz, Wojciech ;

Wdowiak, Kamil ;

Bednarek, Anna ;

Karwasiecka, Dobromila ;

Chudek, Jerzy ;

Wojnar, Jerzy .

POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 :534-541

[36] Acalabrutinib: a real breakthrough in the management of relapsed or refractory chronic lymphocytic leukemia? [J].

Nsiala, Laly ;

Tomowiak, Cecile .

HEMATOLOGIE, 2020, 26 (03) :146-147

[37] Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients [J].

Montillo, Marco ;

Tedeschi, Alessandra ;

Gaidano, Gianluca ;

Coscia, Marta ;

Petrizzi, Valeria Belsito ;

Orlandi, Ester ;

Cascavilla, Nicola ;

Ghia, Paolo ;

Motta, Marina ;

Gallamini, Andrea ;

Frustaci, Anna Maria ;

Rossi, Davide ;

De Paoli, Lorenzo ;

Nichelatti, Michele ;

Morra, Enrica ;

Massaia, Massimo .

HAEMATOLOGICA, 2014, 99 (09) :E159-E161

[38] Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study [J].

Pula, Bartosz ;

Iskierka-Jazdzewska, Elzbieta ;

Dlugosz-Danecka, Monika ;

Szymczyk, Agnieszka ;

Hus, Marek ;

Szeremet, Agnieszka ;

Drozd-Sokolowska, Joanna ;

Waszczuk-Gajda, Anna ;

Zaucha, Jan M. ;

Holojda, Jadwiga ;

Piszczek, Weronika ;

Steckiewicz, Pawel ;

Wojciechowska, Malgorzata ;

Osowiecki, Michal ;

Knopinska-Posluszny, Wanda ;

Dudzinski, Marek ;

Zawirska, Daria ;

Subocz, Edyta ;

Halka, Janusz ;

Pluta, Andrzej ;

Wichary, Ryszard ;

Kumiega, Beata ;

Budziszewska, Bozena K. ;

Jurczak, Wojciech ;

Lech-Maranda, Ewa ;

Giannopoulos, Krzysztof ;

Robak, Tadeusz ;

Jamroziak, Krzysztof .

ANTICANCER RESEARCH, 2020, 40 (07) :4059-4066

[39] Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results [J].

Byrd, John C. ;

Wierda, William G. ;

Schuh, Anna ;

Devereux, Stephen ;

Chaves, Jorge M. ;

Brown, Jennifer R. ;

Hillmen, Peter ;

Martin, Peter ;

Awan, Farrukh T. ;

Stephens, Deborah M. ;

Ghia, Paolo ;

Barrientos, Jacqueline ;

Pagel, John M. ;

Woyach, Jennifer A. ;

Burke, Kathleen ;

Covey, Todd ;

Gulrajani, Michael ;

Hamdy, Ahmed ;

Izumi, Raquel ;

Frigault, Melanie M. ;

Patel, Priti ;

Rothbaum, Wayne ;

Wang, Min Hui ;

O'Brien, Susan ;

Furman, Richard R. .

BLOOD, 2020, 135 (15) :1204-1213

[40] Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies [J].

Kittai, Adam S. ;

Best, Scott ;

Thurlow, Bria ;

Lam, Vi ;

Hashiguchi, Taylor ;

Goodyear, Shaun ;

Persky, Daniel O. ;

Okada, Craig ;

Park, Byung ;

Spurgeon, Stephen E. ;

Danilov, Alexey V. .

HAEMATOLOGICA, 2021, 106 (07) :2022-2025

← 1 2 3 4 5 →